Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Karel F. A. Van Damme"'
Autor:
Karel F. A. Van Damme, Pieter Hertens, Arne Martens, Elisabeth Gilis, Dario Priem, Inge Bruggeman, Amelie Fossoul, Jozefien Declercq, Helena Aegerter, Andy Wullaert, Tino Hochepied, Esther Hoste, Lieselotte Vande Walle, Mohamed Lamkanfi, Savvas N. Savvides, Dirk Elewaut, Bart N. Lambrecht, Geert van Loo
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract A20 serves as a critical brake on NF-κB-dependent inflammation. In humans, polymorphisms in or near the TNFAIP3/A20 gene have been linked to various inflammatory disorders, including systemic lupus erythematosus (SLE) and rheumatoid arthrit
Externí odkaz:
https://doaj.org/article/0bf2e4c99bae45e2afbc4924a4035aa2
Autor:
Elisabeth De Leeuw, Karel F. A. Van Damme, Jozefien Declercq, Cedric Bosteels, Bastiaan Maes, Simon J. Tavernier, Laurent Detalle, Trevor Smart, Sophie Glatt, Nincy Debeuf, Julie Deckers, Sahine Lameire, Stefaan J. Vandecasteele, Nikolaas De Neve, Ingel K. Demedts, Elke Govaerts, Christiane Knoop, Karolien Vanhove, Michel Moutschen, Wim Terryn, Pieter Depuydt, Eva Van Braeckel, Filomeen Haerynck, Tine C. J. Hendrickx, Vanessa Parrein, Marianna Lalla, Claire Brittain, Bart N. Lambrecht
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-11 (2022)
Abstract Background The efficacy and safety of complement inhibition in COVID-19 patients is unclear. Methods A multicenter randomized controlled, open-label trial. Hospitalized COVID-19 patients with signs of systemic inflammation and hypoxemia (PaO
Externí odkaz:
https://doaj.org/article/d9849f76afef44ef98c3e2da010f83fc
Autor:
Karel F. A. Van Damme, Simon Tavernier, Nele Van Roy, Elisabeth De Leeuw, Jozefien Declercq, Cédric Bosteels, Bastiaan Maes, Marieke De Bruyne, Delfien Bogaert, Victor Bosteels, Levi Hoste, Leslie Naesens, Piet Maes, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Pieter Depuydt, Eva Van Braeckel, Filomeen Haerynck, Bart N. Lambrecht
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
The disease course of COVID-19 in patients with immunodeficiencies is unclear, as well as the optimal therapeutic strategy. We report a case of a 37-year old male with common variable immunodeficiency disorder and a severe SARS-CoV-2 infection. After
Externí odkaz:
https://doaj.org/article/4e27c072f0c941c6a4ac764eeba62981